Factors driving persistence to first-line advanced therapies in inflammatory bowel disease: a real-world study from a tertiary referral centre

Marco Vincenzo Lenti(University of Pavia), Antonio Di Sabatino(University of Pavia), Francesco Mordà(University of Pavia), Antonio Lo Bello(University of Pavia), Caterina Mengoli(University Hospital Foundation), Mariangela Delliponti(University of Pavia), Giovanni Santacroce(Università Cattolica del Sacro Cuore), Nicola Aronico, Iara Moreira Frondana(Universidade de São Paulo), Raphael Frondana(University of Pavia), Federica Lepore
Internal and Emergency Medicine
April 25, 2025
10.1007/s11739-025-03943-1
Cited by 3

Related Papers

Decline with age of the respiratory chain activity in human skeletal muscle
|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|1994|340
Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol
|Nutrition|2020|264
Anemia in patients with Covid-19: pathogenesis and clinical significance
|Clinical and Experimental Medicine|2021|154
Role of mucosal immunity and epithelial–vascular barrier in modulating gut homeostasis
|Internal and Emergency Medicine|2023|98
Opening the doors of precision medicine: novel tools to assess intestinal barrier in inflammatory bowel disease and colitis-associated neoplasia
|Gut|2024|96